EBITDA Margin % is calculated as EBITDA divided by its Revenue. BactiQuant AS's EBITDA for the
six
months ended in Dec. 2025 was kr-4.83 Mil. BactiQuant AS's Revenue for the
six
months ended in Dec. 2025 was kr4.21 Mil. Therefore, BactiQuant AS's EBITDA margin for the quarter that ended in Dec. 2025 was -114.89%.
BactiQuant AS (OCSE:BACTIQ) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
BactiQuant AS EBITDA Margin % Related Terms
BactiQuant AS EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for BactiQuant AS's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OCSE:BACTIQ vs VLTO, ZWS, CECO: EBITDA Margin % Comparison
For the Pollution & Treatment Controls subindustry, BactiQuant AS's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BactiQuant AS EBITDA Margin % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, BactiQuant AS's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where BactiQuant AS's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BactiQuant AS (OCSE:BACTIQ) has a EBITDA Margin % of -114.89% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on BactiQuant AS and its competitors. According to the industry distribution chart, BactiQuant AS ranks #2944 out of 3039 companies in the Industrial Products industry, placing it in the top 96.9%.
Is BactiQuant AS's EBITDA Margin % too high?
BactiQuant AS's current EBITDA Margin % is -114.89%. Based on the distribution chart, BactiQuant AS ranks #2944 out of 3039 companies in the Industrial Products industry, which is in the bottom quartile relative to peers. Overall, BactiQuant AS has a GF Score™ of 57/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does BactiQuant AS's EBITDA Margin % compare to VLTO and ZWS?
According to the Industrial Products industry distribution chart, BactiQuant AS ranks #2944 out of 3039 companies for EBITDA Margin %. This places BactiQuant AS in the lower half of its industry. The industry median EBITDA Margin % is 9.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Industrial Products company?
The median EBITDA Margin % among Industrial Products companies is 9.45, based on 3,039 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on BactiQuant AS and its competitors. For the Industrial Products industry, the median EBITDA Margin % is 9.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BactiQuant AS's current EBITDA Margin % is -114.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BactiQuant AS stock overvalued right now?
Based on GuruFocus' analysis, BactiQuant AS (OCSE:BACTIQ) is currently considered Fairly Valued. The stock's GF Value™ is kr2.37, compared to a current price of kr2.52 — trading 6.3% above its estimated fair value. The current EBITDA Margin % is -114.89%. BactiQuant AS's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For BactiQuant AS (OCSE:BACTIQ), the current EBITDA Margin % is -114.89% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BactiQuant AS (OCSE:BACTIQ) Overvalued in 2026?
Based on GuruFocus' analysis, BactiQuant AS stock appears to be overvalued.
The current stock price of kr2.52 is trading 6.3% above its estimated GF Value™ of kr2.37.
GuruFocus considers BactiQuant AS to be Fairly Valued.
Key valuation signals for OCSE:BACTIQ:
EBITDA Margin %: -114.89%
GF Value™: kr2.37 vs. price of kr2.52 (6.3% above fair value)
No single metric tells the full story. See the OCSE:BACTIQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BactiQuant AS focuses on delivering technology that ensures optimum usage and handling of water around the world. The company's activities include the development, production, sale and service of BactiQuant Online and BactiQuant Mobile Lab with associated test kits/substrate for the quantification and detection of bacteria in water. Its segments are Aquaculture, Data Centres, Oil & Gas, Water Utility, Industry, and Pharma. The group's products are BQ Online 2.0 PRO, BQ Online, BQ Mobile Lab, and Analysis Kits.
57GF Score
Get the complete analysis for OCSE:BACTIQ
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OCSE:BACTIQ has been successfully added to your 
